Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1982 Mar;45(3):477–481. doi: 10.1038/bjc.1982.78

Free serum hydroxyproline and total urinary hydroxyproline for the detection of skeletal metastasis.

A B Gasser, D Depierre, B Mermillod, B Courvoisier
PMCID: PMC2010935  PMID: 7041941

Full text

PDF
477

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Basu T. K., Donaldson D., Williams D. C. Urinary hydroxyproline and plasma mucoprotein as an indication of the presence of bone metastases. Oncology. 1974;30(3):197–203. doi: 10.1159/000224956. [DOI] [PubMed] [Google Scholar]
  2. Bonadonna G., Merlino M. J., Myers W. P., Sonenberg M. Urinary hydroxyproline and calcium metabolism in patients with cancer. N Engl J Med. 1966 Aug 11;275(6):298–305. doi: 10.1056/NEJM196608112750603. [DOI] [PubMed] [Google Scholar]
  3. Coombes R. C., Powles T. J., Gazet J. C., Ford H. T., Nash A. G., Sloane J. P., Hillyard C. J., Thomas P., Keyser J. W., Marcus D. A biochemical approach to the staging of human breast cancer. Cancer. 1977 Aug;40(2):937–944. doi: 10.1002/1097-0142(197708)40:2<937::aid-cncr2820400252>3.0.co;2-d. [DOI] [PubMed] [Google Scholar]
  4. Courvoisier B., Zender R. Etude de l'hydroxyprolinurie dans les affections du squelette: ses corrélations avec les autres paramètres du métabolisme osseux. Schweiz Med Wochenschr. 1972 Feb 5;102(5):160–166. [PubMed] [Google Scholar]
  5. Gasser A. B., Depierre D., Courvoisier B. Total urinary and free serum hydroxyproline in metastatic bone disease. Br J Cancer. 1979 Mar;39(3):280–283. doi: 10.1038/bjc.1979.52. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Gasser A., Celada A., Courvoisier B., Depierre D., Hulme P. M., Rinsler M., Williams D., Wootton R. The clinical measurement of urinary total hydroxyproline excretion. Clin Chim Acta. 1979 Aug 1;95(3):487–491. doi: 10.1016/0009-8981(79)90200-6. [DOI] [PubMed] [Google Scholar]
  7. Gielen F., Dequeker J., Drochmans A., Wildiers J., Merlevede M. Relevance of hydroxyproline excretion to bone metastasis in breast cancer. Br J Cancer. 1976 Sep;34(3):279–285. doi: 10.1038/bjc.1976.163. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Grant M. E., Prockop D. J. The biosynthesis of collagen. 1. N Engl J Med. 1972 Jan 27;286(4):194–199. doi: 10.1056/NEJM197201272860406. [DOI] [PubMed] [Google Scholar]
  9. Guzzo C. E., Pachas W. N., Pinals R. S., Krant M. J. Urinary hydroxyproline excretion in patients with cancer. Cancer. 1969 Aug;24(2):382–387. doi: 10.1002/1097-0142(196908)24:2<382::aid-cncr2820240221>3.0.co;2-s. [DOI] [PubMed] [Google Scholar]
  10. Hosley H. F., Taft E. G., Olson K. B., Gates S., Beebe R. T. Hydroxyproline excretion in malignant neoplastic disease. Arch Intern Med. 1966 Dec;118(6):565–571. [PubMed] [Google Scholar]
  11. KLEIN L., LAFFERTY F. W., PEARSON O. H., CURTISS P. H., Jr CORRELATION OF URINARY HYDROXYPROLINE, SERUM ALKALINE PHOSPHATASE AND SKELETAL CALCIUM TURNOVER. Metabolism. 1964 Mar;13:272–284. doi: 10.1016/0026-0495(64)90106-4. [DOI] [PubMed] [Google Scholar]
  12. Kontturi M. J., Sotaniemi E. A., Larmi T. K. Hydroxyproline in the early diagnosis of bone metastases in prostatic cancer. Scand J Urol Nephrol. 1974;8(2):91–95. doi: 10.3109/00365597409132111. [DOI] [PubMed] [Google Scholar]
  13. Posma F. D., Groenewold H., Kluft O., Tuynman F. H. Reference values and analytical performance of the hydroxyproline/creatinine ratio in early morning urine samples. J Clin Chem Clin Biochem. 1981 Apr;19(4):209–212. doi: 10.1515/cclm.1981.19.4.209. [DOI] [PubMed] [Google Scholar]
  14. Powles T. J., Leese C. L., Bondy P. K. Hydroxyproline excretion in patients with breast cancer and response to treatment. Br Med J. 1975 Apr 26;2(5964):164–166. doi: 10.1136/bmj.2.5964.164. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES